The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.
The study has been conducted on the basis of inputs from the industry leaders. Thus, a conscious effort to dive deep and unearth hard to find information pertaining to the growing market landscape and growth prospects over the next few years is clearly visible in the study. The market intelligence report further comprises of discussions about the major vendors operating in the Infectious Disease Rapid Diagnostic Testing space
The advancement in technology has also encouraged the infectious disease rapid diagnostic testing market growth. Investment in research and development has helped in the development of effective diagnostic testing kits, which have helped in the advancement in the market product. However, the lack of proper reimbursement rates may result in lower access for patients to testing, which hinders market growth.
To receive a sample of the global Infectious Disease Rapid Diagnostic Testing market report, click here @ https://www.emergenresearch.com/request-sample-form/269
The prominent players participating in this industry include: Abbott Laboratories, Danaher Corporation, BGI Group, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Luminex Corporation, bioMérieux S.A., Hologic, Inc., Thermo Fisher Scientific Inc., and Becton, Dickinson, and Company, among others.
Key Geographies Profiled in the Report:
The report further emphasizes the developmental strategies undertaken by these companies, including product innovation, new product launches, and technological upgradation. Moreover, the report studies the notable business events observed in this industry, such as mergers & acquisitions, joint ventures, partnerships, corporate deals, and brand promotions. The key industry participants include:
Get access to the full description of the report @ https://www.emergenresearch.com/industry-report/Infectious Disease Rapid Diagnostic Testing-market
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Infectious Disease Rapid Diagnostic Testing Market Segmentation & Impact Analysis
4.1. Infectious Disease Rapid Diagnostic Testing Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing prevalence of infectious diseases
4.2.2.2. Growth in funding for research on infectious disease diagnostics
4.2.3. Market restraints analysis
4.2.3.1. Inadequate reimbursements
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Infectious Disease Rapid Diagnostic Testing Market By Product Insights & Trends Revenue (USD Million)
5.1. Product Dynamics & Market Share, 2019 & 2027
5.1.1. Platforms
5.1.2. Assays
Chapter 6. Infectious Disease Rapid Diagnostic Testing Market By Technology Insights & Trends Revenue (USD Million)
6.1. Technology Dynamics & Market Share, 2019 & 2027
6.1.1. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.1.2. Enzyme Immunoassay (EIA)
6.1.3. Real-Time PCR (q-PCR)
6.1.4. Lateral Flow Immunoassay (LFIA)
6.1.5. Others
Chapter 7. Infectious Disease Rapid Diagnostic Testing Market By Diseases Insights & Trends Revenue (USD Million)
7.1. Diseases Dynamics & Market Share, 2019 & 2027
7.1.1. Bacterial Infection
7.1.1.1. CT/NG
7.1.1.2. HAIs
7.1.1.3. Tuberculosis
7.1.1.4. Others
7.1.2. Viral Infection
7.1.2.1. Hepatitis
7.1.2.2. Influenza Virus
7.1.2.3. HPV
7.1.2.4. HIV-AIDS
7.1.2.5. Others
7.1.3. Others Infections
To Be Continued…!
Key Objectives of the Global Infectious Disease Rapid Diagnostic Testing Market Report:
Request customization of the market report @ https://www.emergenresearch.com/request-for-customization-form/269
Thank you for reading our report. To know more about the report or for any queries regarding the customization of the report, please connect with us. We will make sure our team provides the necessary assistance and designs your report according to your requirements.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com